Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study

BACKGROUND: Many patients with solid tumours or nonmyeloid haematopoietic tumours develop symptomatic anaemia, which has a major impact on quality of life (QoL). The efficacy of erythropoiesis-stimulating agents (ESAs) in improving QoL and reducing blood transfusions has been widely demonstrated. Bi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Med Oncol
Main Authors: Rosti, Giovanni, Petrini, Mario, Bosi, Alberto, Galieni, Piero, Bernardi, Daniele, Giglio, Gianfranco, Dorotea, Laura, Falini, Brunangelo, Scelzi, Elvira, Veltri, Enzo, Castelli, Roberto, Longagnani, Chiara, Raggi, Tommaso, Simonetti, Federico
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2016
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5298451/
https://ncbi.nlm.nih.gov/pubmed/28203295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834016670554
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares